sec filing
CL
NASDAQ · CLYM
Climb Bio, Inc.
Healthcare · Biotechnology
$14.57
Down-$0.49 (-3.25%)
Updated Aug 30, 2026, 1:14 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 157.17M
- P/E ratio
- -3.33
- Dividend yield
- 0.00%
- 52-week range
- $5.87 – $18.33
- Volume
- 840.93K
- Avg. volume
- 598.77K
Price performance
CLYM price history
1M range · 20 trading sessions · Daily adjusted prices
CLYM closed at $14.57 after 20 trading sessions, up 23.37% for the selected period.
- Last close
- $14.57
- Period change
- +23.37%
- Period low
- $11.81
- Period high
- $17.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $14.86 | $15.13 | $14.37 | $14.57 | 840.93K |
| Aug 27, 2026 | $16.09 | $16.33 | $14.935 | $15.06 | 1.56M |
| Aug 26, 2026 | $17.72 | $17.80 | $16.01 | $16.08 | 1.39M |
| Aug 25, 2026 | $16.75 | $18.33 | $16.75 | $17.84 | 1.2M |
| Aug 24, 2026 | $17.27 | $17.41 | $16.05 | $16.40 | 1.18M |
| Aug 21, 2026 | $17.26 | $17.71 | $17.00 | $17.28 | 957.41K |
| Aug 20, 2026 | $17.16 | $17.45 | $16.72 | $17.02 | 903.93K |
| Aug 19, 2026 | $18.09 | $18.135 | $16.58 | $17.34 | 1.29M |
| Aug 18, 2026 | $16.90 | $17.53 | $16.45 | $17.39 | 1.16M |
| Aug 17, 2026 | $16.25 | $17.52 | $15.84 | $17.44 | 1.87M |
| Aug 14, 2026 | $15.06 | $17.00 | $14.24 | $16.33 | 2.5M |
| Aug 13, 2026 | $14.58 | $15.21 | $14.505 | $14.73 | 1.58M |
| Aug 12, 2026 | $13.97 | $14.55 | $13.61 | $14.39 | 1.32M |
| Aug 11, 2026 | $13.67 | $13.98 | $13.23 | $13.85 | 707.2K |
| Aug 10, 2026 | $13.80 | $13.86 | $13.20 | $13.54 | 779.55K |
| Aug 7, 2026 | $14.26 | $14.53 | $13.61 | $14.00 | 910.27K |
| Aug 6, 2026 | $12.44 | $14.00 | $12.44 | $14.00 | 1.43M |
| Aug 5, 2026 | $12.56 | $12.76 | $12.145 | $12.47 | 1.1M |
| Aug 4, 2026 | $12.10 | $12.76 | $12.07 | $12.56 | 1.03M |
| Aug 3, 2026 | $11.985 | $11.985 | $11.36 | $11.81 | 847.53K |
Latest CLYM news
The latest Smart Investors Daily articles mentioning CLYM.
Stock researchResearch & News · Analysis
Loading stock research…

